First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 167.47 USD -0.2%
Updated: Apr 25, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Abbvie Inc

Revenue
54.3B USD
Cost of Revenue
-18.2B USD
Gross Profit
36.1B USD
Operating Expenses
-19.5B USD
Operating Income
16.6B USD
Other Expenses
-11.7B USD
Net Income
4.8B USD

Margins Comparison
Abbvie Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Abbvie Inc
NYSE:ABBV
295.7B USD
66%
30%
9%
US
Amgen Inc
NASDAQ:AMGN
143.7B USD
70%
29%
24%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.5B USD
87%
39%
37%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.6B USD
86%
32%
30%
AU
CSL Ltd
ASX:CSL
134.5B AUD
52%
26%
17%
US
Gilead Sciences Inc
NASDAQ:GILD
81.5B USD
78%
34%
21%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
75%
-33%
-33%
US
Moderna Inc
NASDAQ:MRNA
40.1B USD
31%
-62%
-69%
US
Biogen Inc
NASDAQ:BIIB
28.9B USD
74%
21%
12%
KR
Celltrion Inc
KRX:068270
36.8T KRW
48%
30%
25%
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD
75%
16%
12%
Country US
Market Cap 295.7B USD
Gross Margin
66%
Operating Margin
30%
Net Margin
9%
Country US
Market Cap 143.7B USD
Gross Margin
70%
Operating Margin
29%
Net Margin
24%
Country US
Market Cap 102.5B USD
Gross Margin
87%
Operating Margin
39%
Net Margin
37%
Country US
Market Cap 97.6B USD
Gross Margin
86%
Operating Margin
32%
Net Margin
30%
Country AU
Market Cap 134.5B AUD
Gross Margin
52%
Operating Margin
26%
Net Margin
17%
Country US
Market Cap 81.5B USD
Gross Margin
78%
Operating Margin
34%
Net Margin
21%
Country US
Market Cap 43.1B USD
Gross Margin
75%
Operating Margin
-33%
Net Margin
-33%
Country US
Market Cap 40.1B USD
Gross Margin
31%
Operating Margin
-62%
Net Margin
-69%
Country US
Market Cap 28.9B USD
Gross Margin
74%
Operating Margin
21%
Net Margin
12%
Country KR
Market Cap 36.8T KRW
Gross Margin
48%
Operating Margin
30%
Net Margin
25%
Country IE
Market Cap 26.6B USD
Gross Margin
75%
Operating Margin
16%
Net Margin
12%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Abbvie Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Abbvie Inc
NYSE:ABBV
295.7B USD
35%
4%
16%
13%
US
Amgen Inc
NASDAQ:AMGN
143.7B USD
136%
8%
13%
11%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.5B USD
23%
18%
22%
44%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.6B USD
16%
13%
15%
32%
AU
CSL Ltd
ASX:CSL
134.5B AUD
15%
7%
11%
9%
US
Gilead Sciences Inc
NASDAQ:GILD
81.5B USD
26%
9%
18%
14%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
-28%
-21%
-27%
-39%
US
Moderna Inc
NASDAQ:MRNA
40.1B USD
-29%
-21%
-23%
-41%
US
Biogen Inc
NASDAQ:BIIB
28.9B USD
8%
5%
9%
8%
KR
Celltrion Inc
KRX:068270
36.8T KRW
5%
4%
6%
4%
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD
9%
5%
7%
8%
Country US
Market Cap 295.7B USD
ROE
35%
ROA
4%
ROCE
16%
ROIC
13%
Country US
Market Cap 143.7B USD
ROE
136%
ROA
8%
ROCE
13%
ROIC
11%
Country US
Market Cap 102.5B USD
ROE
23%
ROA
18%
ROCE
22%
ROIC
44%
Country US
Market Cap 97.6B USD
ROE
16%
ROA
13%
ROCE
15%
ROIC
32%
Country AU
Market Cap 134.5B AUD
ROE
15%
ROA
7%
ROCE
11%
ROIC
9%
Country US
Market Cap 81.5B USD
ROE
26%
ROA
9%
ROCE
18%
ROIC
14%
Country US
Market Cap 43.1B USD
ROE
-28%
ROA
-21%
ROCE
-27%
ROIC
-39%
Country US
Market Cap 40.1B USD
ROE
-29%
ROA
-21%
ROCE
-23%
ROIC
-41%
Country US
Market Cap 28.9B USD
ROE
8%
ROA
5%
ROCE
9%
ROIC
8%
Country KR
Market Cap 36.8T KRW
ROE
5%
ROA
4%
ROCE
6%
ROIC
4%
Country IE
Market Cap 26.6B USD
ROE
9%
ROA
5%
ROCE
7%
ROIC
8%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More